Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300

Mutational Analyses of Open Reading Frames within thevraSROperon and Their Roles in the Cell Wall Stress Response ofStaphylococcus aureus

(2011) N. McCallum et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Interface Between Antibiotic Resistance and Virulence in Staphylococcus aureus and Its Impact Upon Clinical Outcomes

(2011) D. R. Cameron et al.   CLINICAL INFECTIOUS DISEASES

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype

(2010) Luay F. Abu-Qatouseh et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The cell envelope stress response mediated by the LiaFSRLm three-component system of Listeria monocytogenes is controlled via the phosphatase activity of the bifunctional histidine kinase LiaSLm

(2010) F. Fritsch et al.   MICROBIOLOGY-SGM

Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils

(2010) Bettina Löffler et al.   PLoS Pathogens

Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

(2009) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA

(2009) K. C. Horne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of Reduced Vancomycin Susceptibility in Methicillin‐SusceptibleStaphylococcus aureus

(2009) Satish K. Pillai et al.   CLINICAL INFECTIOUS DISEASES

Paradoxical Relationship between the Clinical Outcome ofStaphylococcus aureusBacteremia and the Minimum Inhibitory Concentration of Vancomycin

(2009) James Price et al.   CLINICAL INFECTIOUS DISEASES

Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR

(2009) Y. Kato et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The LiaFSR System Regulates the Cell Envelope Stress Response in Streptococcus mutans

(2009) P. Suntharalingam et al.   JOURNAL OF BACTERIOLOGY

Reduced Susceptibility to Vancomycin Influences Pathogenicity inStaphylococcus aureusInfection

(2009) Anton Y. Peleg et al.   JOURNAL OF INFECTIOUS DISEASES

A Point Mutation in theagrLocus rather than Expression of the Panton‐Valentine Leukocidin Caused Previously Reported Phenotypes inStaphylococcus aureusPneumonia and Gene Regulation

(2009) Amer E. Villaruz et al.   JOURNAL OF INFECTIOUS DISEASES

Is High Vancomycin Minimum Inhibitory Concentration a Good Marker to Predict the Outcome of Methicillin‐ResistantStaphylococcus aureusBacteremia?

(2009) Antonio Lalueza et al.   JOURNAL OF INFECTIOUS DISEASES

GenBank

(2009) Dennis A. Benson et al.   NUCLEIC ACIDS RESEARCH

Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus

(2009) M. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comparative Study of the Susceptibilities of Major Epidemic Clones of Methicillin-Resistant Staphylococcus aureus to Oxacillin and to the New Broad-Spectrum Cephalosporin Ceftobiprole

(2008) M. Chung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus

(2008) B. P. Howden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia

(2008) Benjamin P Howden et al.   BMC MICROBIOLOGY

Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus

(2008) Jeffrey C. Hageman et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comparison of Virulence in Community‐Associated Methicillin‐ResistantStaphylococcus aureusPulsotypes USA300 and USA400 in a Rat Model of Pneumonia

(2008) Christopher P. Montgomery et al.   JOURNAL OF INFECTIOUS DISEASES

Virulence Gene Expression in Human Community‐AcquiredStaphylococcus aureusInfection

(2008) Jennifer A. Loughman et al.   JOURNAL OF INFECTIOUS DISEASES

Identification of the First Vancomycin Intermediate-Resistant Staphylococcus aureus (VISA) Isolate from a Hospital in Portugal

(2008) S. Gardete et al.   Microbial Drug Resistance

Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis

(2008) Paul A. Majcherczyk et al.   MICROBIAL PATHOGENESIS

A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway

(2008) Sarah Dubrac et al.   MOLECULAR MICROBIOLOGY